NCT02081014View on ClinicalTrials.gov

Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Hypoglycemia
Interventions
DRUG

G-Pen Mini™ (glucagon injection)

stable, pre-mixed, liquid glucagon for subcutaneous injection

Trial Locations (1)

77030

Baylor College of Medicine, Children's Nutritional Research Center, Texas Children's Hospital, Houston

Sponsors
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Emissary International LLC

INDUSTRY

lead

Xeris Pharmaceuticals

INDUSTRY